Role of Th1/17 in gastric tumor initiation triggered by CTLA4 dysregulation

Th1/17 在 CTLA4 失调引发的胃肿瘤发生中的作用

基本信息

  • 批准号:
    8688191
  • 负责人:
  • 金额:
    $ 22.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Stomach (gastric) cancer is a common lethal cancer. Development of gastric cancer is thought to proceed from gastric inflammation, metaplasia, dysplasia to carcinoma. Extensive studies have established Helicobacter pylori (HP) infection as a risk factor for gastric cancer, but the association of HP with gastric cancers varies in populations, likely reflecting a complex interaction with genetic and environmental factors. Host susceptibility factors may play an important role but are less well-understood. Independent genetic studies have associated human gastric cancer with polymorphisms of the CTLA4 locus that predict a reduction in CTLA4 expression. Since CTLA4 is exclusively expressed in T lymphocytes and has been demonstrated as a prototypical inhibitor of anti-tumor immunity in other types of cancers, observations from the genetic study suggest a paradoxical role of CTLA4 in gastric carcinogenesis. Defect in CTLA4-based regulation could trigger an aberrant inflammatory cascade that lead to gastric tumorigenesis. The study of the host susceptibility factors in gastric cancer has been hindered by a dearth of rodent models that spontaneously develop gastric inflammation and tumors. Rather than using the "all-or-nothing" "knockout" CTLA4 models that do not reflect natural variations of CTLA4 expressions among individual humans, we have created CTLA4 shRNA "knockdown" (KD) models to mimic the subtle reductions of CTLA4 expression predicted by polymorphisms of human CTLA4 locus. We found that CTLA4 modulation could cause spontaneous gastric mucosal metaplasia independently of Helicobacter infection. We hypothesize that Reduced Expression of a CTLA4 in T Lymphocytes Spontaneously Initiates Gastric Tumorigenesis through Dysregulated Th1 and/or Th17 Effector Differentiation. We will test this hypothesis by dissecting the roles of Th1 and Th17 in gastric metaplasia induced by CTLA4 modulation, using genetic mutant animals deficient in Th1 or Th17. This study aims to provide novel and in-depth knowledge on how a master inhibitor of adaptive immunity suppresses initiation of tumorigenesis, with a long-term goal to identify strategies for gastric cancer prevention.
描述(由申请人提供):胃(胃)癌症是一种常见的致死癌。胃癌的发展被认为从胃炎,化生,发育不全到癌进行。广泛的研究已将幽门螺杆菌(HP)感染确立为胃癌的危险因素,但是HP与胃癌的关联在人群中有所不同,可能反映了与遗传和环境因素的复杂相互作用。宿主敏感性因素可能起着重要作用,但理解不太善良。独立的遗传研究将人类胃癌与CTLA4基因座的多态性相关联,该基因座预测CTLA4表达的降低。由于CTLA4在T淋巴细胞中仅表达,并且已被证明是其他类型的癌症中抗肿瘤免疫的原型抑制剂,因此遗传研究的观察结果表明,CTLA4在胃癌发生中的矛盾作用。基于CTLA4的调节缺陷可能会引发异常的炎症级联反应,从而导致胃肿瘤发生。对自发发展胃炎和肿瘤的啮齿动物模型的缺乏,对胃癌中宿主易感因素的研究受到了阻碍。我们没有使用不反映单个人类中CTLA4表达式自然变化的“全或全部”“敲除” CTLA4模型,而是创建了CTLA4 Shrna“敲低”(KD)模型来模仿CTLA4人类CTLA4 locus losus locus locus locus locuss ctla4表达的细微降低。我们发现,CTLA4调节可能会引起自发性胃粘膜化生,而不是独立于螺旋杆菌感染。我们假设在T淋巴细胞中CTLA4的表达降低会自发地通过失调的TH1和/或TH17效应子分化引起胃肿瘤发生。我们将使用遗传突变动物在TH1或TH17中阐述Th1和Th17在CTLA4调制引起的胃中植物中的作用来检验这一假设。这项研究旨在提供有关适应性免疫的主抑制剂如何抑制肿瘤发生的新知识的新颖和深入的知识,其长期目标是确定预防胃癌的策略。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Autoimmunity as a double agent in tumor killing and cancer promotion.
  • DOI:
    10.3389/fimmu.2014.00116
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Toomer KH;Chen Z
  • 通讯作者:
    Chen Z
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zhibin Chen其他文献

Zhibin Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zhibin Chen', 18)}}的其他基金

The role of type 2 inflammation in the initiation and progression of metaplastic differentiation and neoplastic transformation of gastric epithelia
2型炎症在胃上皮化生分化和肿瘤转化的起始和进展中的作用
  • 批准号:
    10633096
  • 财政年份:
    2020
  • 资助金额:
    $ 22.67万
  • 项目类别:
The role of type 2 inflammation in the initiation and progression of metaplastic differentiation and neoplastic transformation of gastric epithelia
2型炎症在胃上皮化生分化和肿瘤转化的起始和进展中的作用
  • 批准号:
    10172874
  • 财政年份:
    2020
  • 资助金额:
    $ 22.67万
  • 项目类别:
The role of type 2 inflammation in the initiation and progression of metaplastic differentiation and neoplastic transformation of gastric epithelia
2型炎症在胃上皮化生分化和肿瘤转化的起始和进展中的作用
  • 批准号:
    10405615
  • 财政年份:
    2020
  • 资助金额:
    $ 22.67万
  • 项目类别:
The role of type 2 inflammation in the initiation and progression of metaplastic differentiation and neoplastic transformation of gastric epithelia
2型炎症在胃上皮化生分化和肿瘤转化的起始和进展中的作用
  • 批准号:
    10737935
  • 财政年份:
    2020
  • 资助金额:
    $ 22.67万
  • 项目类别:
The role of type 2 inflammation in the initiation and progression of metaplastic differentiation and neoplastic transformation of gastric epithelia
2型炎症在胃上皮化生分化和肿瘤转化的起始和进展中的作用
  • 批准号:
    10598700
  • 财政年份:
    2020
  • 资助金额:
    $ 22.67万
  • 项目类别:
Mucosal surface and skin protection by MHC class I-based immune regulation
基于 MHC I 类的免疫调节保护粘膜表面和皮肤
  • 批准号:
    10291421
  • 财政年份:
    2018
  • 资助金额:
    $ 22.67万
  • 项目类别:
Mucosal surface and skin protection by MHC class I-based immune regulation
基于 MHC I 类的免疫调节保护粘膜表面和皮肤
  • 批准号:
    10053700
  • 财政年份:
    2018
  • 资助金额:
    $ 22.67万
  • 项目类别:
Mucosal surface and skin protection by MHC class I-based immune regulation
基于 MHC I 类的免疫调节保护粘膜表面和皮肤
  • 批准号:
    10516738
  • 财政年份:
    2018
  • 资助金额:
    $ 22.67万
  • 项目类别:
Role of Th1/17 in gastric tumor initiation triggered by CTLA4 dysregulation
Th1/17 在 CTLA4 失调引发的胃肿瘤发生中的作用
  • 批准号:
    8570484
  • 财政年份:
    2013
  • 资助金额:
    $ 22.67万
  • 项目类别:
The quantitative biology of CTLA4 splice variants in T1D
T1D 中 CTLA4 剪接变体的定量生物学
  • 批准号:
    7798450
  • 财政年份:
    2009
  • 资助金额:
    $ 22.67万
  • 项目类别:

相似国自然基金

基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
  • 批准号:
    51009131
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
  • 批准号:
    50178004
  • 批准年份:
    2001
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
  • 批准号:
    10663469
  • 财政年份:
    2023
  • 资助金额:
    $ 22.67万
  • 项目类别:
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
一体化、个体化、智能处方(I3P)临床试验网络
  • 批准号:
    10822651
  • 财政年份:
    2023
  • 资助金额:
    $ 22.67万
  • 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
  • 批准号:
    10603436
  • 财政年份:
    2023
  • 资助金额:
    $ 22.67万
  • 项目类别:
Supplement for Role of Environmental Weathering and Gastrointestinal Digestion on the Bioavailability and Toxicity of Microplastic and Cadmium Mixtures
补充环境风化和胃肠消化对微塑料和镉混合物的生物利用度和毒性的作用
  • 批准号:
    10854398
  • 财政年份:
    2023
  • 资助金额:
    $ 22.67万
  • 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
  • 批准号:
    10456380
  • 财政年份:
    2023
  • 资助金额:
    $ 22.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了